ReviewJournal for immunotherapy of cancer2025

Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care.

Suzanne L Topalian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.